1. Current status of Adriamycin and daunorubicin in cancer treatment;Wiernik,1980
2. Comparison of Adriamycin uptake in chick embryo heart and liver cells and murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity;Johnson;Cancer Res,1986
3. Liposomal protection of Adriamycin-induced cardiotoxicity in mice;Rahman;Cancer Res,1980
4. CEA-related antigens: molecular biology and clinical significance;Shively;CRC Crit Rev Oncol,1985
5. A covalent binding of daunomycin and Adriamycin to antibodies, with retention of both drug and antibody activities;Hurwitz;Cancer Res,1975